Literature DB >> 28815579

"Histological characteristics of HPV-associated and -independent squamous cell carcinomas of the vulva: A study of 1,594 cases".

Natalia Rakislova1, Omar Clavero2, Laia Alemany2,3, Adela Saco1, Beatriz Quirós2, Belen Lloveras4, Maria Alejo5, Michael Pawlita6, Wim Quint7, Marta Del Pino8, Silvia de Sanjose2,3, Jaume Ordi1.   

Abstract

There are at least two different etio-pathogenic pathways for the development of vulvar squamous cell carcinoma (VSCC): one associated with infection by human papillomavirus (HPV) and another independent of HPV. We aimed to describe the histological characteristics of HPV-associated and -independent tumors and to determine the best strategy to identify HPV in VSCC. A single paraffin block was available for review from a series of 1,594 VSCCs. In all cases HPV DNA detection was analyzed using the SPF10PCR/DEIA/LiPA25 system and p16 immunohistochemistry (IHC). A tumor was considered as unquestionably HPV-associated if both HPV DNA and p16 IHC were positive. A tumor was considered indisputably HPV-independent if both HPV DNA and p16 IHC were negative. Two groups of tumors were classified as non-conclusive: (1) HPV DNA+/p16- and (2) HPV DNA-/p16+. WHO typing and a thorough histological evaluation were conducted in all cases. Four hundred and forty-one tumors were HPV DNA+ with 367 cases (23.0%) being HPV DNA+/p16+. The latter tumors were more frequently basaloid or warty (49.8%), but 36.5% were of the keratinizing type; 1,153 tumors were HPV DNA-, with 1,060 cases (66.5%) being HPV DNA-/p16-. These HPV DNA-/p16- tumors were mostly keratinizing (81.2%) but were occasionally basaloid or warty (5.2%). The features of HPV DNA-/p16+ cases (n = 93) were similar to those of the HPV-associated VSCC, and HPV DNA+/p16- (n = 74) cases had a more diverse profile, although they were more similar to HPV-independent tumors. Several histological characteristics were more frequently associated with HPV-related VSCC (koilocytotic-like change, necrosis, moderate to marked pleomorphism, invasive front in nests; p < 0.001), however, none of these characteristics allowed differentiation between HPV-associated and -independent VSCC. In conclusion, histological criteria do not allow differentiation between HPV-associated and -independent VSCC. p16 Alone is a clinically easy strategy to determine HPV status in VSCC.
© 2017 UICC.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28815579     DOI: 10.1002/ijc.31006

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  17 in total

1.  CD274 (PD-L1), CDKN2A (p16), TP53, and EGFR immunohistochemical profile in primary, recurrent and metastatic vulvar cancer.

Authors:  Sofia Lérias; Susana Esteves; Fernanda Silva; Mário Cunha; Daniela Cochicho; Luís Martins; Ana Félix
Journal:  Mod Pathol       Date:  2019-12-16       Impact factor: 7.842

2.  Recurrent genetic alterations and biomarker expression in primary and metastatic squamous cell carcinomas of the vulva.

Authors:  Deyin Xing; Yuehua Liu; Hyeon Jin Park; Inji Baek; Hung Tran; Gloria Cheang; Jorge Novo; Jessica Dillon; Andres Matoso; Emily Farmer; Max A Cheng; Ya-Chea Tsai; Kara Lombardo; Michael G Conner; Russell Vang; Chien-Fu Hung; Tzyy-Choou Wu; Wei Song
Journal:  Hum Pathol       Date:  2019-08-19       Impact factor: 3.466

3.  High-risk human papillomavirus-associated vulvar neoplasia among women living with human immunodeficiency virus in Zambia.

Authors:  Fred Maate; Peter Julius; Stepfanie Siyumbwa; Leeya Pinder; Trevor Kaile; Mulindi Mwanahamuntu; Groesbeck Parham
Journal:  Afr J Lab Med       Date:  2022-05-12

4.  Molecular landscape of vulvovaginal squamous cell carcinoma: new insights into molecular mechanisms of HPV-associated and HPV-independent squamous cell carcinoma.

Authors:  Abeer M Salama; Amir Momeni-Boroujeni; Chad Vanderbilt; Marc Ladanyi; Robert Soslow
Journal:  Mod Pathol       Date:  2021-10-14       Impact factor: 8.209

5.  Vulvar intraepithelial neoplasia treated with a combination of surgical excision and laser ablation during pregnancy.

Authors:  Liangcheng Wang; Ayaka Kawabe; Atsuko Kikugawa; Akiyoshi Takagi; Kenichi Kuromaki
Journal:  Clin Case Rep       Date:  2018-08-13

6.  Expanding the Morphologic, Immunohistochemical, and HPV Genotypic Features of High-grade Squamous Intraepithelial Lesions of the Vulva With Morphology Mimicking Differentiated Vulvar Intraepithelial Neoplasia and/or Lichen Sclerosus.

Authors:  Laurie M Griesinger; Heather Walline; Grace Y Wang; Guadalupe Lorenzatti Hiles; Kathryn C Welch; Hope K Haefner; Richard W Lieberman; Stephanie L Skala
Journal:  Int J Gynecol Pathol       Date:  2021-05-01       Impact factor: 3.326

7.  Prevalence of human papillomavirus and its prognostic value in vulvar cancer: A systematic review and meta-analysis.

Authors:  Jianxin Zhang; Yang Zhang; Zhenyu Zhang
Journal:  PLoS One       Date:  2018-09-26       Impact factor: 3.240

8.  Role of human papillomavirus infection in the etiology of vulvar cancer in Italian women.

Authors:  Mario Preti; John Charles Rotondo; Dana Holzinger; Leonardo Micheletti; Niccolò Gallio; Sandrine McKay-Chopin; Christine Carreira; Sebastiana Silvana Privitera; Reiko Watanabe; Ruediger Ridder; Michael Pawlita; Chiara Benedetto; Massimo Tommasino; Tarik Gheit
Journal:  Infect Agent Cancer       Date:  2020-04-01       Impact factor: 2.965

9.  Clinicopathologic Diagnosis of Differentiated Vulvar Intraepithelial Neoplasia and Vulvar Aberrant Maturation.

Authors:  Tania Day; Alexandra Marzol; Ross Pagano; Ken Jaaback; James Scurry
Journal:  J Low Genit Tract Dis       Date:  2020-10       Impact factor: 3.842

10.  Diagnostic Criteria for Differentiated Vulvar Intraepithelial Neoplasia and Vulvar Aberrant Maturation.

Authors:  Debra S Heller; Tania Day; Jill I Allbritton; James Scurry; Gianluigi Radici; Kathryn Welch; Mario Preti
Journal:  J Low Genit Tract Dis       Date:  2021-01-01       Impact factor: 3.842

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.